FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213464351> ?p ?o ?g. }

• W3213464351 endingPage "1893" @default.
• W3213464351 startingPage "1875" @default.
• W3213464351 abstract "The accumulation of advanced glycation end products (AGEs) have been implicated in the development and progression of diabetic vasculopathy. However, the role of profilin-1 as a multifunctional actin-binding protein in AGEs-induced atherosclerosis (AS) is largely unknown.To explore the potential role of profilin-1 in the pathogenesis of AS induced by AGEs, particularly in relation to the Janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) signaling pathway.Eighty-nine individuals undergoing coronary angiography were enrolled in the study. Plasma cytokine levels were detected using ELISA kits. Rat aortic vascular smooth muscle cells (RASMCs) were incubated with different compounds for different times. Cell proliferation was determined by performing the MTT assay and EdU staining. An AGEs-induced vascular remodeling model was established in rats and histological and immunohistochemical analyses were performed. The mRNA and protein levels were detected using real-time PCR and Western blot analysis, respectively. In vivo, shRNA transfection was performed to verify the role of profilin-1 in AGEs-induced proatherogenic mediator release and aortic remodeling. Statistical analyses were performed using SPSS 22.0 software.Compared with the control group, plasma levels of profilin-1 and receptor for AGEs (RAGE) were significantly increased in patients with coronary artery disease, especially in those complicated with diabetes mellitus (P < 0.01). The levels of profilin-1 were positively correlated with the levels of RAGE (P < 0.01); additionally, the levels of both molecules were positively associated with the degree of coronary artery stenosis (P < 0.01). In vivo, tail vein injections of AGEs induced the release of proatherogenic mediators, such as asymmetric dimethylarginine, intercellular adhesion molecule-1, and the N-terminus of procollagen III peptide, concomitant with apparent aortic morphological changes and significantly upregulated expression of the profilin-1 mRNA and protein in the thoracic aorta (P < 0.05 or P < 0.01). Downregulation of profilin-1 expression with an shRNA significantly attenuated AGEs-induced proatherogenic mediator release (P < 0.05) and aortic remodeling. In vitro, incubation of vascular smooth muscle cells (VSMCs) with AGEs significantly promoted cell proliferation and upregulated the expression of the profilin-1 mRNA and protein (P < 0.05). AGEs (200 μg/mL, 24 h) significantly upregulated the expression of the STAT3 mRNA and protein and JAK2 protein, which was blocked by a JAK2 inhibitor (T3042-1) and/or STAT3 inhibitor (T6308-1) (P < 0.05). In addition, pretreatment with T3042-1 or T6308-1 significantly inhibited AGEs-induced RASMC proliferation (P < 0.05).AGEs induce proatherogenic events such as VSMC proliferation, proatherogenic mediator release, and vascular remodeling, changes that can be attenuated by silencing profilin-1 expression. These results suggest a crucial role for profilin-1 in AGEs-induced vasculopathy." @default.
• W3213464351 created "2021-11-22" @default.
• W3213464351 creator A5008795836 @default.
• W3213464351 creator A5019919601 @default.
• W3213464351 creator A5020584166 @default.
• W3213464351 creator A5020794752 @default.
• W3213464351 creator A5044093768 @default.
• W3213464351 creator A5045627167 @default.
• W3213464351 date "2021-11-15" @default.
• W3213464351 modified "2023-10-01" @default.
• W3213464351 title "Profilin-1 is involved in macroangiopathy induced by advanced glycation end products <i>via</i> vascular remodeling and inflammation" @default.
• W3213464351 cites W1752045965 @default.
• W3213464351 cites W1975224849 @default.
• W3213464351 cites W1978711899 @default.
• W3213464351 cites W1979381191 @default.
• W3213464351 cites W1989844606 @default.
• W3213464351 cites W2000258452 @default.
• W3213464351 cites W2021018646 @default.
• W3213464351 cites W2070021254 @default.
• W3213464351 cites W2087570408 @default.
• W3213464351 cites W2094497330 @default.
• W3213464351 cites W2099174317 @default.
• W3213464351 cites W2110906204 @default.
• W3213464351 cites W2113338980 @default.
• W3213464351 cites W2114208826 @default.
• W3213464351 cites W2114663414 @default.
• W3213464351 cites W2122750179 @default.
• W3213464351 cites W2124425532 @default.
• W3213464351 cites W2127531078 @default.
• W3213464351 cites W2144184190 @default.
• W3213464351 cites W2146172538 @default.
• W3213464351 cites W2154749915 @default.
• W3213464351 cites W2171294019 @default.
• W3213464351 cites W2274924551 @default.
• W3213464351 cites W2524518321 @default.
• W3213464351 cites W2531028757 @default.
• W3213464351 cites W2604282925 @default.
• W3213464351 cites W2736084414 @default.
• W3213464351 cites W2739084432 @default.
• W3213464351 cites W2744066028 @default.
• W3213464351 cites W2751264050 @default.
• W3213464351 cites W2758433057 @default.
• W3213464351 cites W2766187024 @default.
• W3213464351 cites W2767865599 @default.
• W3213464351 cites W2771721456 @default.
• W3213464351 cites W2795546591 @default.
• W3213464351 cites W2807650913 @default.
• W3213464351 cites W2897217378 @default.
• W3213464351 cites W2897364906 @default.
• W3213464351 cites W2916558784 @default.
• W3213464351 cites W2946948136 @default.
• W3213464351 cites W2952750934 @default.
• W3213464351 cites W2953536521 @default.
• W3213464351 cites W2954234788 @default.
• W3213464351 cites W2955525868 @default.
• W3213464351 cites W2964952983 @default.
• W3213464351 cites W2970718734 @default.
• W3213464351 cites W2995950935 @default.
• W3213464351 cites W3184122306 @default.
• W3213464351 cites W4213140092 @default.
• W3213464351 doi "https://doi.org/10.4239/wjd.v12.i11.1875" @default.
• W3213464351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34888013" @default.
• W3213464351 hasPublicationYear "2021" @default.
• W3213464351 type Work @default.
• W3213464351 sameAs 3213464351 @default.
• W3213464351 citedByCount "3" @default.
• W3213464351 countsByYear W32134643512022 @default.
• W3213464351 countsByYear W32134643512023 @default.
• W3213464351 crossrefType "journal-article" @default.
• W3213464351 hasAuthorship W3213464351A5008795836 @default.
• W3213464351 hasAuthorship W3213464351A5019919601 @default.
• W3213464351 hasAuthorship W3213464351A5020584166 @default.
• W3213464351 hasAuthorship W3213464351A5020794752 @default.
• W3213464351 hasAuthorship W3213464351A5044093768 @default.
• W3213464351 hasAuthorship W3213464351A5045627167 @default.
• W3213464351 hasBestOaLocation W32134643511 @default.
• W3213464351 hasConcept C126322002 @default.
• W3213464351 hasConcept C134018914 @default.
• W3213464351 hasConcept C142724271 @default.
• W3213464351 hasConcept C147990577 @default.
• W3213464351 hasConcept C169760540 @default.
• W3213464351 hasConcept C170493617 @default.
• W3213464351 hasConcept C2776914184 @default.
• W3213464351 hasConcept C2778857457 @default.
• W3213464351 hasConcept C2780942790 @default.
• W3213464351 hasConcept C71924100 @default.
• W3213464351 hasConcept C86803240 @default.
• W3213464351 hasConceptScore W3213464351C126322002 @default.
• W3213464351 hasConceptScore W3213464351C134018914 @default.
• W3213464351 hasConceptScore W3213464351C142724271 @default.
• W3213464351 hasConceptScore W3213464351C147990577 @default.
• W3213464351 hasConceptScore W3213464351C169760540 @default.
• W3213464351 hasConceptScore W3213464351C170493617 @default.
• W3213464351 hasConceptScore W3213464351C2776914184 @default.
• W3213464351 hasConceptScore W3213464351C2778857457 @default.
• W3213464351 hasConceptScore W3213464351C2780942790 @default.
• W3213464351 hasConceptScore W3213464351C71924100 @default.
• W3213464351 hasConceptScore W3213464351C86803240 @default.

• next